インターベンショナルカーディオロジーデバイス市場：デバイスタイプ、材料、技術、用途、エンドユーザー別-2025-2030年世界予測

インターベンショナルカーディオロジーデバイス市場は、2024年には187億8,000万米ドルとなり、2025年には199億6,000万米ドル、CAGR6.38%で成長し、2030年には272億3,000万米ドルに達すると予測されています。

急速なヘルスケア革新が進む現在、インターベンショナル・カーディオロジー機器市場は大きな変革期を迎えています。このダイナミックな分野は、最先端技術と洗練された手技によって複雑な心血管系疾患に対処することに主眼を置いています。臨床医も業界の利害関係者も同様に、臨床的ニーズと技術的ブレークスルーが融合し、患者の転帰を向上させる道が開かれつつあるのを目の当たりにしています。精密で低侵襲な手技が主役となるにつれ、より安全で効果的なソリューションに対する要求の高まりに後押しされ、市場は規模だけでなく高度化も進んでいます。

技術的進歩、規制改革、研究開発への投資拡大が相俟って、市場力学の再構築に寄与しています。このような環境は、投資家や意思決定者にとって、現在の戦略を再評価し、革新的なソリューションに軸足を移し、新たな市場動向に対応する好機となります。臨床エビデンス、実世界での応用、進化するインフラの相互作用が、この市場の成長ストーリーのバックボーンを形成しています。利害関係者は今、次世代技術の統合に注力する一方で、伝統的で実績のある調査手法がおろそかにならないようにし、革新性と信頼性のバランスを取る必要があります。

この概要では、変革的シフト、市場セグメンテーションの考察、地域別開発、競合情勢、戦略的提言など、今日の市場シナリオをより深く掘り下げていきます。

インターベンショナル・カーディオロジー機器市場における変革的変化

インターベンショナル・カーディオロジー機器市場は、業界標準と診療規範を再定義し続けるいくつかの変革的シフトによって特徴付けられてきました。過去数年間で、技術導入、患者中心のケアモデル、規制ガイドラインの劇的な変化が、心血管治療へのアプローチ方法のパラダイムシフトを促進しました。

従来の侵襲的手法から低侵襲的手法への進化がこの変革の最前線にあります。高度な画像システム、洗練されたカテーテルベースのインターベンション、レーザーと熱分解炭素技術の統合などの開発は、診断精度と手技の安全性の向上を推進しています。高度な画像診断モダリティにより、臨床医は解剖学的構造をかつてないほど明瞭に可視化できるようになり、介入の精度が向上しています。さらに、薬剤溶出性ステントや生分解性製品の登場は、急性期の臨床ニーズと長期的な患者のリスクの両方に対応する新しいクラスのデバイスを提供しました。

こうした変革の重要な側面のひとつに、個別化治療プロトコルの台頭があります。患者のプロファイルが多様化するにつれ、固有の解剖学的・病理学的状態に基づく機器のカスタマイズが、重要な焦点分野として浮上してきました。規制当局も承認プロセスを合理化し、革新的ソリューションの迅速な導入を促進しています。このような迅速な統合は、効率性の向上だけでなく、患者ケアの継続的改善のための強固な枠組みを構築することにもつながります。

さらに、包括的なデジタルヘルスエコシステムの確立に向けた動きは、リアルタイムのデータ分析と遠隔モニタリングを日常診療に統合するための基盤を築いた。こうしたエコシステムにより、ヘルスケア専門家は情報に基づいた迅速な意思決定を行うことができるようになり、その結果、処置の成果が最適化され、全体的なケアの継続性が向上します。

市場力学を牽引する主要セグメンテーション洞察

市場を徹底的に分析することで、インターベンショナルカーディオロジー機器の状況をしっかりと理解することができる複雑なセグメンテーションが明らかになります。デバイスの種類から市場を調査すると、カテーテル、クロージャーデバイス、ガイドワイヤー、IVUSプラス画像システム、ステント、血栓除去デバイスなどのカテゴリーが研究開発の中心的な柱として浮かび上がってくる。カテーテルのカテゴリーでは、吸引カテーテル、バルーンカテーテル、ガイディングカテーテルを詳細に分析しました。特にバルーンカテーテルは、用途と性能の微妙な違いを反映し、オーバー・ザ・ワイヤー型バルーンカテーテルとラピッド・エクスチェンジ型バルーンカテーテルに分類されます。さらに、閉鎖器具はアクティブ型とパッシブ型に分類され、ガイドワイヤーは診断用とインターベンション用の仕様で分析されます。このセグメンテーションのもう一つの重要な要素であるステントは、ベアメタルステント、生分解性ステント、薬剤溶出性ステントに分類され、それぞれに明確な利点と市場の可能性があります。

材料に基づく分析では、金属とポリマーの使用に焦点が当てられ、強度と耐久性で知られるコバルトクロムや、良好な放射線透過性で知られるプラチナクロムなどの金属が、市場の大きなシェアを占めています。材料は性能を左右するだけでなく、コスト構造や生体適合性にも影響し、これらは臨床機器の選択に不可欠な要素です。

技術を考慮した場合、市場はバルーン血管形成技術、高度な心エコー技術、レーザーベースのイメージング、熱分解炭素技術など、さまざまな革新的アプローチに区分されます。この技術的セグメンテーションは、手技精度の向上、合併症発生率の低下、患者の安全性向上を提供する機器への動向を強調するものです。さらに、アプリケーションに基づくセグメンテーションは、主要な手技領域に光を当てています。神経血管造影と末梢血管形成術の両方を統合した血管造影インターベンションは、冠動脈形成術と経皮的冠動脈インターベンションを含む冠動脈インターベンションを補完します。さらに、経カテーテル弁修復術と弁置換術の両方を含む弁と心臓の構造的介入がますます重要性を増しています。最後に、エンドユーザーに基づくセグメンテーションは、外来手術センター、心臓専門センター、私立と公的機関、研究機関にさらに分化した病院など、それぞれの使用パターンを反映しています。各セグメンテーション要素は、市場動向と将来の成長軌道に関する独自の洞察を提供し、注目と投資が最も高いリターンをもたらしそうな場所を示します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化社会における心血管疾患の増加により、インターベンショナルカーディオロジーデバイスの需要が高まっています。
    • 予防ヘルスケア対策の認知度と採用の増加により、心臓病介入の需要が高まっています。
    • 低侵襲手術の増加により、インターベンショナルカーディオロジーデバイスの採用が増加
  • 抑制要因
    • インターベンショナルカーディオロジーデバイスにおける初期コストの高さとサプライチェーンの混乱
  • 機会
    • 機器への人工知能の統合が進むことで、インターベンション心臓学の新たな領域が開かれる
    • 介入心臓病学ソリューションの開発に向けた継続的な政府の取り組みと資金提供
  • 課題
    • デジタルおよびリモート監視ソリューションの統合に伴うデータのプライバシーとセキュリティに関する懸念
• 市場セグメンテーション分析
  • 応用：インターベンショナルカーディオロジーデバイスにおける血管造影介入の活用
  • デバイスタイプ：インターベンショナルカーディオロジーデバイスにおけるバルーンカテーテルの進歩
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 インターベンショナルカーディオロジーデバイス市場：デバイスタイプ別

• カテーテル
  • 吸引カテーテル
  • バルーンカテーテル
    • ワイヤー経由バルーンカテーテル
    • 迅速交換バルーンカテーテル
  • ガイドカテーテル
• 閉鎖装置
  • アクティブクロージャーデバイス
  • パッシブクロージャーデバイス
• ガイドワイヤー
  • 診断用ガイドワイヤー
  • 介入ガイドワイヤー
• IVUS+イメージングシステム
• ステント
  • ベアメタルステント
  • 生分解性ステント
  • 薬剤溶出ステント
• 血栓除去デバイス

第7章 インターベンショナルカーディオロジーデバイス市場：素材別

• 金属
  • コバルトクロム
  • プラチナクロム
• ポリマー

第8章 インターベンショナルカーディオロジーデバイス市場：技術別

• バルーン血管形成術技術
• 心エコー検査技術
• レーザーベースのイメージング
• 熱分解炭素技術

第9章 インターベンショナルカーディオロジーデバイス市場：用途別

• 血管造影介入
  • 神経血管造影
  • 末梢血管形成術
• 冠動脈インターベンション
  • 冠動脈形成術
  • 経皮的冠動脈インターベンション
• 弁および構造的心臓介入
  • 経カテーテル弁修復術
  • 経カテーテル弁置換術

第10章 インターベンショナルカーディオロジーデバイス市場：エンドユーザー別

• 外来手術センター
• 心臓センター
• 病院
  • 私立病院
  • 公立病院
• 調査機関

第11章 南北アメリカのインターベンショナルカーディオロジーデバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のインターベンショナルカーディオロジーデバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのインターベンショナルカーディオロジーデバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AngioDynamics, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company,
• Biosense Webster, Inc. by Johnson & Johnson Services, Inc.
• Biosensors International Group, Ltd.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical Inc.
• Cordis Corporation by Cardinal Health company
• Edward Lifesciences Corporation
• Edwards Lifesciences Corporation
• Endologix, Inc.
• GE Healthcare
• iVascular SLU
• Lepu Medical Technology（Beijing）Co., Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• Siemens Healthineers AG
• Teleflex Incorporated
• Terumo Corporation
• Volcano Corporation by Philips Holding USA Inc.

LIST OF FIGURES

• FIGURE 1. INTERVENTIONAL CARDIOLOGY DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. INTERVENTIONAL CARDIOLOGY DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. INTERVENTIONAL CARDIOLOGY DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. INTERVENTIONAL CARDIOLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. INTERVENTIONAL CARDIOLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INTERVENTIONAL CARDIOLOGY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTERVENTIONAL CARDIOLOGY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY OVER-THE-WIRE BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY RAPID-EXCHANGE BALLOON CATHETER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ACTIVE CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PASSIVE CLOSURE DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY IVUS+ IMAGING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BIODEGRADABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COBALT-CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PLATINUM-CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ECHOCARDIOGRAPHY TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY LASER-BASED IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PYROLYTIC CARBON TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PERIPHERAL ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 87. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 90. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 91. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 92. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 93. ARGENTINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 96. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 101. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 102. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 105. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 106. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 107. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 108. BRAZIL INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 109. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 111. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 112. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 113. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 114. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 115. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 116. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 117. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 120. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 121. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 122. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 123. CANADA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 124. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 126. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 127. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 129. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 130. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 131. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 132. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 135. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 136. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 137. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 138. MEXICO INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 139. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 144. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 146. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 147. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 150. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 151. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 152. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 153. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 154. UNITED STATES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 155. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 157. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 158. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 160. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 161. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 162. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 163. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 166. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 167. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 168. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 169. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 170. ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 171. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 172. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 173. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 174. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 175. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 176. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 177. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 178. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 179. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 182. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 183. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 184. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 185. AUSTRALIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 186. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 187. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 188. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 189. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 191. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 192. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 193. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 194. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 197. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 198. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 199. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 200. CHINA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 201. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 202. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 203. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 204. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 206. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 207. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 208. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 209. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 212. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 213. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 214. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 215. INDIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 216. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 218. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 219. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 221. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 222. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 223. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 224. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 227. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 228. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 229. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 230. INDONESIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 231. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 232. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 233. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 234. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 235. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 236. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 237. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 238. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 239. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 242. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 243. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 244. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 245. JAPAN INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 246. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 247. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 248. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 249. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 251. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 252. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 253. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 254. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 255. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 257. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 258. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 259. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 260. MALAYSIA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 261. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 262. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 263. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 264. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 265. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 266. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 267. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 268. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 269. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 272. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 273. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 274. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 275. PHILIPPINES INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 276. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 278. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 279. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 281. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 282. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 283. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY METALS, 2018-2030 (USD MILLION)
• TABLE 284. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 285. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY ANGIOGRAPHIC INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 287. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CORONARY INTERVENTION, 2018-2030 (USD MILLION)
• TABLE 288. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY VALVE AND STRUCTURAL HEART INTERVENTIONS, 2018-2030 (USD MILLION)
• TABLE 289. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 290. SINGAPORE INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 291. SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 292. SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
• TABLE 293. SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2030 (USD MILLION)
• TABLE 294. SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY CLOSURE DEVICES, 2018-2030 (USD MILLION)
• TABLE 295. SOUTH KOREA INTERVENTIONAL CARDIOLOGY DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
• TABLE 296. SOUTH KO

The Interventional Cardiology Devices Market was valued at USD 18.78 billion in 2024 and is projected to grow to USD 19.96 billion in 2025, with a CAGR of 6.38%, reaching USD 27.23 billion by 2030.

In the current era of rapid healthcare innovation, the interventional cardiology devices market is undergoing a significant transformation. This dynamic sector is centered on addressing complex cardiovascular conditions through cutting-edge technologies and refined procedural techniques. Clinicians and industry stakeholders alike are witnessing a convergence of clinical need and technological breakthroughs that are paving the way for enhanced patient outcomes. As precision and minimally invasive procedures take center stage, the market has not only grown in volume but also in sophistication, driven by increasing demands for safer, more effective solutions.

Technological advancements, regulatory reforms, and growing investments in research and development have collectively contributed to reshaping market dynamics. This environment provides an opportune moment for investors and decision-makers to re-evaluate current strategies, pivot to innovative solutions, and address emerging market trends. The interplay between clinical evidence, real-world application, and evolving infrastructure forms the backbone of this market's growth story. Stakeholders must now focus on integrating next-generation technologies while ensuring that traditional, proven methodologies are not neglected, thereby striking a balance between innovation and reliability.

This overview sets the stage for a deeper dive into transformative shifts, segmentation insights, regional developments, competitive landscapes, and strategic recommendations that collectively define the market narrative today.

Transformative Shifts in the Interventional Cardiology Devices Market

The interventional cardiology devices market has been characterized by several transformative shifts that continue to redefine industry standards and practice norms. Over the past few years, dramatic changes in technology adoption, patient-centric care models, and regulatory guidelines have catalyzed a paradigm shift in how cardiovascular interventions are approached.

The evolution from traditional invasive methods to minimally invasive techniques has been at the forefront of this transformation. Developments such as advanced imaging systems, refined catheter-based interventions, and the integration of laser and pyrolytic carbon technologies are driving enhancements in diagnostic accuracy and procedural safety. Enhanced imaging modalities now enable clinicians to visualize anatomical structures with unprecedented clarity, thereby improving the precision of interventions. Moreover, the advent of drug-eluting stents and biodegradable products has provided a new class of devices that address both acute clinical needs and long-term patient risks.

One of the key aspects of these transformative shifts is the rise in personalized treatment protocols. As patient profiles become more diverse, customization of devices based on unique anatomical and pathological conditions has emerged as a critical area of focus. Regulatory bodies have also streamlined approval processes, fostering quicker adoption of innovative solutions. This fast-tracked integration supports not just increased efficiency but also builds a robust framework for continuous improvement in patient care.

Furthermore, the push towards establishing comprehensive digital health ecosystems has laid the groundwork for integrating real-time data analytics and remote monitoring into everyday practice. These ecosystems empower healthcare professionals to make informed decisions rapidly, thereby optimizing procedural outcomes and improving overall care continuity.

Key Segmentation Insights Driving Market Dynamics

A thorough analysis of the market reveals intricate segmentation that enables a robust understanding of the interventional cardiology devices landscape. When examining the market through the lens of device type, categories such as catheters, closure devices, guidewires, IVUS plus imaging systems, stents, and thrombectomy devices emerge as central pillars of research and development. Within the category of catheters, a deeper analysis differentiates between aspiration catheters, balloon catheters, and guiding catheters. Notably, the balloon catheters further divide into over-the-wire balloon catheters and rapid-exchange balloon catheters, reflecting nuanced differences in application and performance. Additionally, closure devices are categorized into active and passive variants, while guidewires are analyzed by diagnostic and interventional specifications. Stents, another critical component of this segmentation, are innovated into bare metal stents, biodegradable stents, and drug-eluting stents, each with distinct benefits and market potential.

Analyses based on material focus on the use of metals and polymers, where metals such as cobalt-chromium, known for its strength and durability, and platinum-chromium, recognized for its favorable radiopacity, dominate a significant share of the market. Materials not only dictate performance but also impact cost structures and biocompatibility, which are essential factors in clinical device selection.

When technology is considered, the market is segmented into various innovative approaches including balloon angioplasty technology, advanced echocardiography techniques, laser-based imaging, and pyrolytic carbon technology. This technological segmentation underscores the trend towards devices that offer improved procedural accuracy, lower complication rates, and higher patient safety. Furthermore, application-based segmentation sheds light on key procedural domains. Angiographic interventions, which integrate both neurovascular angiography and peripheral angioplasty, complement coronary interventions that include coronary angioplasty and percutaneous coronary interventions. Additionally, valve and structural heart interventions, which involve both transcatheter valve repair and valve replacement, have become increasingly significant. Lastly, segmentation based on end users reflects distinct usage patterns across ambulatory surgical centers, specialized cardiac centers, hospitals with further differentiation into private and public institutions, as well as research institutes. Each segmentation factor provides unique insights on market trends and future growth trajectories, indicating where attention and investment are likely to yield the highest returns.

Based on Device Type, market is studied across Catheters, Closure Devices, Guidewires, IVUS+ Imaging System, Stents, and Thrombectomy Devices. The Catheters is further studied across Aspiration Catheters, Balloon Catheters, and Guiding Catheters. The Balloon Catheters is further studied across Over-The-Wire Balloon Catheter and Rapid-Exchange Balloon Catheter. The Closure Devices is further studied across Active Closure Devices and Passive Closure Devices. The Guidewires is further studied across Diagnostic Guidewires and Interventional Guidewires. The Stents is further studied across Bare Metal Stents, Biodegradable Stents, and Drug-Eluting Stents.

Based on Material, market is studied across Metals and Polymers. The Metals is further studied across Cobalt-Chromium and Platinum-Chromium.

Based on Technology, market is studied across Balloon Angioplasty Technology, Echocardiography Techniques, Laser-Based Imaging, and Pyrolytic Carbon Technology.

Based on Application, market is studied across Angiographic Interventions, Coronary Intervention, and Valve and Structural Heart Interventions. The Angiographic Interventions is further studied across Neurovascular Angiography and Peripheral Angioplasty. The Coronary Intervention is further studied across Coronary Angioplasty and Percutaneous Coronary Intervention. The Valve and Structural Heart Interventions is further studied across Transcatheter Valve Repair and Transcatheter Valve Replacement.

Based on End Users, market is studied across Ambulatory Surgical Centers, Cardiac Centers, Hospitals, and Research Institutes. The Hospitals is further studied across Private Hospitals and Public Hospitals.

Critical Regional Trends Shaping Market Growth

Navigating the interventional cardiology devices landscape requires a careful examination of regional trends that provide context to global market dynamics. The Americas continue to be a leading region where technological innovation, robust healthcare infrastructure, and progressive clinical practices fuel significant market growth. The region benefits from high adoption rates of state-of-the-art devices, driven by well-funded healthcare systems and supportive regulatory environments that encourage clinical research and technological trials.

In Europe, the Middle East and Africa (EMEA) region, the market has witnessed a steady upward trend, marked by a blend of mature healthcare institutions with emerging markets. This region is characterized by strategic collaborations among manufacturers and clinical centers, leading to a synergistic exploitation of novel technologies. The focus here is on quality improvement initiatives, which align with increased investments in regulatory compliance and clinical efficacy.

The Asia-Pacific region is rapidly emerging as a hotbed of innovation. Spurred by increasing affluence, expanding middle-class populations, and continuous improvements in healthcare infrastructure, this region is seeing a surge in demand for both established and cutting-edge interventional cardiology devices. In addition, governmental initiatives and private investments are paving the way for large-scale improvements in diagnostic and interventional facilities, further cementing Asia-Pacific's role as an influential player on the global stage. Together, these regional insights help in understanding diversified growth patterns and the need for tailored strategies to meet local market requirements.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Market Leaders and Key Competitors

The competitive landscape of the interventional cardiology devices market is defined by several key players, each contributing to a robust and innovative product portfolio. Global giants such as Abbott Laboratories and AngioDynamics, Inc. are known for their relentless focus on research and development, ensuring that new technologies are quickly integrated into clinical practice. B. Braun Melsungen AG and Becton, Dickinson and Company have set benchmarks in quality and operational excellence that have been widely recognized in the industry.

Biosense Webster, Inc. by Johnson & Johnson Services, Inc., along with Biosensors International Group, Ltd., are distinguished for their breakthroughs in device miniaturization and advanced imaging solutions. Companies like Biotronik SE & Co. KG have carved a niche in delivering both innovation and reliability, while Boston Scientific Corporation and Cardinal Health, Inc. have effectively harnessed insights from cross-functional research to drive growth. Manufacturers such as Cook Medical Inc. and Cordis Corporation by Cardinal Health are front-runners in establishing new norms in device safety and efficacy. Edward Lifesciences Corporation, Edwards Lifesciences Corporation, and Endologix, Inc. continue to push the envelope with pioneering device technologies that address complex heart conditions.

Other notable contributors in this competitive landscape include GE Healthcare, iVascular SLU, Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Merit Medical Systems, Inc., Siemens Healthineers AG, Teleflex Incorporated, Terumo Corporation, and Volcano Corporation by Philips Holding USA Inc. Their contributions demonstrate a robust commitment to innovation, cost efficiency, and enhanced clinical outcomes. The interplay between clinical evidence and state-of-the-art technology has set a high bar, ensuring that continuous innovation remains a key driver in meeting the ever-evolving needs of cardiology interventions.

The report delves into recent significant developments in the Interventional Cardiology Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company,, Biosense Webster, Inc. by Johnson & Johnson Services, Inc., Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Cordis Corporation by Cardinal Health company, Edward Lifesciences Corporation, Edwards Lifesciences Corporation, Endologix, Inc., GE Healthcare, iVascular SLU, Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, Merit Medical Systems, Inc., Siemens Healthineers AG, Teleflex Incorporated, Terumo Corporation, and Volcano Corporation by Philips Holding USA Inc.. Strategic Recommendations for Market Stakeholders

For industry leaders and decision-makers, the evolving landscape of interventional cardiology devices offers myriad opportunities to enhance strategic positioning and drive sustained growth. It is imperative that organizations place a premium on innovation, with an emphasis on research and development initiatives that focus on both incremental improvements and breakthrough technologies.

A focal point should be the adoption of personalized treatment avenues, which not only improve patient outcomes but also cater to the increasing demands for tailored interventions. Vivifying collaborations between clinicians, device manufacturers, and academic researchers are instrumental in accelerating the discovery and validation of next-generation devices. Leaders in this space should actively invest in emerging technologies such as advanced imaging, laser-based diagnostic systems, and robust digital health solutions that integrate real-time analytics.

Additionally, focusing on strategic expansion into rapidly growing regions, particularly in the Asia-Pacific and EMEA sectors, can yield significant competitive advantages. Localized product customization, coupled with regulatory compliance, will enable better market penetration and customer engagement. Competitive benchmarking against established players provides valuable insights into process optimization and quality assurance practices. Furthermore, diversifying the device portfolio and harnessing material innovations such as cobalt-chromium and platinum-chromium alloys can help balance cost structures with performance needs.

Finally, a robust post-market surveillance system is critical to track device performance and identify areas for product enhancement. Leveraging data analytics to continuously refine product design and patient care protocols ensures that innovations remain aligned with clinical needs and regulatory expectations. These strategic measures are essential not only for retaining market leadership but also for paving the way toward sustainable long-term growth.

Conclusion and Future Outlook

As the interventional cardiology devices market continues to evolve, the convergence of technology, patient-specific applications, and strategic regional expansion is setting the stage for a future defined by innovation and superior clinical outcomes. The detailed segmentation insights illustrate the complexity and nuance of this competitive landscape, while regional trends highlight the differential growth trajectories and market potential across various territories.

Industry leaders who are agile enough to respond to these changes will undoubtedly find themselves better positioned to capture emerging opportunities. Advancements in imaging technology, refined procedural devices, and cost-effective material innovations offer new dimensions of performance that address both current clinical challenges and future patient needs. The competitive landscape reinforces the importance of quality and robust research, as continuous improvements are paramount in meeting the evolving demands of cardiology interventions.

In summary, the market's future rests on maintaining a balance between tried-and-tested practices and the integration of disruptive innovations. The dialog between technology and clinical efficacy is only set to intensify, signaling a transformative period that will redefine the standards of cardiovascular care. The insights provided herein serve as a valuable guidepost for decision-makers looking to navigate this complex and rapidly evolving field.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing cardiovascular diseases among aging populations offer rising demand for interventional cardiology devices
    • 5.1.1.2. Increasing awareness and adoption of preventive healthcare measures are pushing the demand higher for cardiology interventions
    • 5.1.1.3. Rise in minimally invasive surgeries leads to greater adoption of interventional cardiology devices
  • 5.1.2. Restraints
    • 5.1.2.1. High initial cost and supply chain disruption in interventional cardiology devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing integration of artificial intelligence in devices opens new frontiers in interventional cardiology
    • 5.1.3.2. Ongoing government initiatives and funding for the development of interventional cardiology solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concern associated with data privacy and security with the integration of digital and remote monitoring solutions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Application: Utilisation of angiographic interventions in interventional cardiology devices
  • 5.2.2. Device Type: Rising advancement in balloon catheters in Interventional Cardiology Devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Interventional Cardiology Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Catheters
  • 6.2.1. Aspiration Catheters
  • 6.2.2. Balloon Catheters
    • 6.2.2.1. Over-The-Wire Balloon Catheter
    • 6.2.2.2. Rapid-Exchange Balloon Catheter
  • 6.2.3. Guiding Catheters
• 6.3. Closure Devices
  • 6.3.1. Active Closure Devices
  • 6.3.2. Passive Closure Devices
• 6.4. Guidewires
  • 6.4.1. Diagnostic Guidewires
  • 6.4.2. Interventional Guidewires
• 6.5. IVUS+ Imaging System
• 6.6. Stents
  • 6.6.1. Bare Metal Stents
  • 6.6.2. Biodegradable Stents
  • 6.6.3. Drug-Eluting Stents
• 6.7. Thrombectomy Devices

7. Interventional Cardiology Devices Market, by Material

• 7.1. Introduction
• 7.2. Metals
  • 7.2.1. Cobalt-Chromium
  • 7.2.2. Platinum-Chromium
• 7.3. Polymers

8. Interventional Cardiology Devices Market, by Technology

• 8.1. Introduction
• 8.2. Balloon Angioplasty Technology
• 8.3. Echocardiography Techniques
• 8.4. Laser-Based Imaging
• 8.5. Pyrolytic Carbon Technology

9. Interventional Cardiology Devices Market, by Application

• 9.1. Introduction
• 9.2. Angiographic Interventions
  • 9.2.1. Neurovascular Angiography
  • 9.2.2. Peripheral Angioplasty
• 9.3. Coronary Intervention
  • 9.3.1. Coronary Angioplasty
  • 9.3.2. Percutaneous Coronary Intervention
• 9.4. Valve and Structural Heart Interventions
  • 9.4.1. Transcatheter Valve Repair
  • 9.4.2. Transcatheter Valve Replacement

10. Interventional Cardiology Devices Market, by End Users

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Cardiac Centers
• 10.4. Hospitals
  • 10.4.1. Private Hospitals
  • 10.4.2. Public Hospitals
• 10.5. Research Institutes

11. Americas Interventional Cardiology Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Interventional Cardiology Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Interventional Cardiology Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Johnson & Johnson acquires V-Wave to expand cardiovascular device offerings
  • 14.3.2. Simpson Interventions acolyte catheter system secures FDA advance designation
  • 14.3.3. Echopoint Medical secures series A funding to propel iKOr system through FDA approval
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AngioDynamics, Inc.
• 3. B. Braun Melsungen AG
• 4. Becton, Dickinson and Company,
• 5. Biosense Webster, Inc. by Johnson & Johnson Services, Inc.
• 6. Biosensors International Group, Ltd.
• 7. Biotronik SE & Co. KG
• 8. Boston Scientific Corporation
• 9. Cardinal Health, Inc.
• 10. Cook Medical Inc.
• 11. Cordis Corporation by Cardinal Health company
• 12. Edward Lifesciences Corporation
• 13. Edwards Lifesciences Corporation
• 14. Endologix, Inc.
• 15. GE Healthcare
• 16. iVascular SLU
• 17. Lepu Medical Technology (Beijing) Co., Ltd.
• 18. Medtronic plc
• 19. Merit Medical Systems, Inc.
• 20. Siemens Healthineers AG
• 21. Teleflex Incorporated
• 22. Terumo Corporation
• 23. Volcano Corporation by Philips Holding USA Inc.